Clinical trial
Utilization of Lexiscan (Regadenoson)in the Cardiac Catheterization Lab to Achieve Maximal Hyperemia for Coronary Physiologic Assessment With Fractional Flow Reserve
NCT01161121 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utilization of Lexiscan (Regadenoson)in the Cardiac Catheterization Lab to Achieve Maximal Hyperemia for Coronary Physiologic Assessment With Fractional Flow Reserve
- Lead sponsor
- St. Louis University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- April 30, 2013
- Enrollment
- 46 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.